Ryo Okazaki
Third Department of Medicine
Teikyo University Chiba Medical Center
3426-3 Anesaki
Ichihara
Japan
Name/email consistency: high
- Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis. Okazaki, R., Hagino, H., Ito, M., Sone, T., Nakamura, T., Mizunuma, H., Fukunaga, M., Shiraki, M., Nishizawa, Y., Ohashi, Y., Matsumoto, T. Osteoporos. Int (2012)
- Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D₃ load in Japanese subjects. Okazaki, R., Sugimoto, T., Kaji, H., Fujii, Y., Shiraki, M., Inoue, D., Endo, I., Okano, T., Hirota, T., Kurahashi, I., Matsumoto, T. J. Bone Miner. Metab. (2011)
- Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Okazaki, R., Inoue, D., Shibata, M., Saika, M., Kido, S., Ooka, H., Tomiyama, H., Sakamoto, Y., Matsumoto, T. Endocrinology (2002)
- Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Okazaki, R., Toriumi, M., Fukumoto, S., Miyamoto, M., Fujita, T., Tanaka, K., Takeuchi, Y. Endocrinology (1999)
- A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. Okazaki, R., Chikatsu, N., Nakatsu, M., Takeuchi, Y., Ajima, M., Miki, J., Fujita, T., Arai, M., Totsuka, Y., Tanaka, K., Fukumoto, S. J. Clin. Endocrinol. Metab. (1999)
